Qiong Du

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0003-4830-9704

发表论文 87 篇 · 总被引 1040 次 · h-index 17

代表论文

• Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism (2025 · Gastroenterology · 被引 31)
• CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network (2024 · Frontiers in Pharmacology · 被引 21)
• Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study (2024 · Pharmaceuticals · 被引 10)
• Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma (2024 · Computational and Structural Biotechnology Journal · 被引 9)
• Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system (2025 · Frontiers in Pharmacology · 被引 6)
• Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma (2025 · Human Vaccines & Immunotherapeutics · 被引 5)